Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 24;19(1):176.
doi: 10.1186/s12904-020-00682-2.

Physicians' clinical prediction of survival in head and neck cancer patients in the palliative phase

Affiliations

Physicians' clinical prediction of survival in head and neck cancer patients in the palliative phase

Arta Hoesseini et al. BMC Palliat Care. .

Abstract

Background: The prognosis of patients with incurable head and neck cancer (HNC) is a relevant topic. The mean survival of these patients is 5 months but may vary from weeks to more than 3 years. Discussing the prognosis early in the disease trajectory enables patients to make well-considered end-of-life choices, and contributes to a better quality of life and death. However, physicians often are reluctant to discuss prognosis, partly because of the concern to be inaccurate. This study investigated the accuracy of physicians' clinical prediction of survival of palliative HNC patients.

Methods: This study was part of a prospective cohort study in a tertiary cancer center. Patients with incurable HNC diagnosed between 2008 and 2011 (n = 191), and their treating physician were included. Analyses were conducted between July 2018 and February 2019. Patients' survival was clinically predicted by their physician ≤3 weeks after disclosure of the palliative diagnosis. The clinical prediction of survival in weeks (CPS) was based on physicians' clinical assessment of the patient during the outpatient visits. More than 25% difference between the actual survival (AS) and the CPS was regarded as a prediction error. In addition, when the difference between the AS and CPS was 2 weeks or less, this was always considered as correct.

Results: In 59% (n = 112) of cases survival was overestimated. These patients lived shorter than predicted by their physician (median AS 6 weeks, median CPS 20 weeks). In 18% (n = 35) of the cases survival was correctly predicted. The remaining 23% was underestimated (median AS 35 weeks, median CPS 20 weeks). Besides the differences in AS and CPS, no other significant differences were found between the three groups. There was worse accuracy when predicting survival closer to death: out of the 66 patients who survived 6 weeks or shorter, survival was correctly predicted in only eight (12%).

Conclusion: Physicians tend to overestimate the survival of palliative HNC patients. This optimism can result in suboptimal use of palliative and end-of-life care. The future development of a prognostic model that provides more accurate estimates, could help physicians with personalized prognostic counseling.

Keywords: Counseling; Head and neck cancer; Palliative care; Prediction; Prognosis; Survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flowchart summarizing inclusion and exclusion criteria. CPS = Clinical prediction of survival
Fig. 2
Fig. 2
Clinical prediction of survival (CPS) versus actual survival (AS) for each individual. Each point represents a patient. Points around the 45 degree line represent patients who lived as long as predicted, points above the line represent patients who lived shorter than predicted, and points below the line represent patients who lived longer than predicted. Pearson correlation coefficient of 0.042 (p = 0.568). Four outliers are not shown (AS 220; 194; 192; 183 weeks versus a CPS of 20; 20; 12; 20 weeks)
Fig. 3
Fig. 3
Overall survival function of the actual survival (AS, blue curve) versus the clinical prediction of survival (CPS, red curve) in all patients

References

    1. Hoofd-halskanker . Netherlands Comprehensive Cancer Organisation. 2018.
    1. Ledeboer QC, van der Schroeff MP, Pruyn JF, de Boer MF. Baatenburg de Jong RJ, van der Velden LA. Survival of patients with palliative head and neck cancer. Head Neck. 2011;33(7):1021–1026. doi: 10.1002/hed.21572. - DOI - PubMed
    1. Dronkers EA, Mes SW, Wieringa MH, van der Schroeff MP, Baatenburg de Jong RJ. Noncompliance to guidelines in head and neck cancer treatment; associated factors for both patient and physician. BMC Cancer. 2015;15:515. doi: 10.1186/s12885-015-1523-3. - DOI - PMC - PubMed
    1. Forbes K. Palliative care in patients with cancer of the head and neck. Clin Otolaryngol Allied Sci. 1997;22(2):117–122. doi: 10.1046/j.1365-2273.1997.00872.x. - DOI - PubMed
    1. Lokker ME, Offerman MP, van der Velden LA, de Boer MF, Pruyn JF, Teunissen SC. Symptoms of patients with incurable head and neck cancer: prevalence and impact on daily functioning. Head Neck. 2013;35(6):868–876. doi: 10.1002/hed.23053. - DOI - PubMed